Comparison of matrix metalloproteinase activation after focal cortical ischemia in young adult and aged mice

Journal of Neuroscience Research

Volumn 90, Issue 1, 2012, Pages 203-212

  Liguz Lecznar, Monika ^a   Ziemka Nalecz, Malgorzata ^b   Aleksy, Monika ^a   Kossut, Malgorzata ^a   Skangiel Kramska, Jolanta ^a   Nowicka, Dorota ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Aging; Gelatinases; Matrix metalloproteinase 9; Photothrombosis

Indexed keywords

GELATINASE A; GELATINASE B;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CELL NUCLEUS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GROUPS BY AGE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOSIS; ZYMOGRAPHY;

AGE FACTORS; ANIMALS; BRAIN ISCHEMIA; CELL NUCLEUS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NEURONS; PHOSPHOPYRUVATE HYDRATASE; TIME FACTORS;

EID: 81255168197     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22715     Document Type: Article

References (41)

1. Amantea D, Corasaniti MT, Mercuri NB, Bernardi G, Bagetta G. 2008. Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion. Neuroscience 152: 8-17.
2. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. 2000. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab. 20: 1681-1689.
3. Benuck M, Banay-Schwartz M, DeGuzman T, Lajtha A. 1996. Changes in brain protease activity in aging. J Neurochem 67: 2019-2029.
4. Bernath E, Kupina N, Liu MC, Hayes RL, Meegan C, Wang KK. 2006. Elevation of cytoskeletal protein breakdown in aged Wistar rat brain. Neurobiol Aging 27: 624-632.
5. Chondrogianni N, Fragoulis EG, Gonos ES. 2002. Protein degradation during aging: the lysosome-, the calpain-and the proteasome-dependent cellular proteolytic systems. Biogerontology 3: 121-123.
6. Cuadrado E, Rosell A, Penalba A, Slevin M, Alvarez-Saban J, Ortega-Aznar A, Montaner J. 2009. Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 8: 3191-3197.
7. Dong X, Song YN, Liu WG, Guo XL. 2009. Mmp-9, a potential target for cerebral ischemic treatment. Curr Neuropharmacol 7: 269-275.
8. Dzwonek J, Rylski M, Kaczmarek L. 2004. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 567: 129-135.
9. Fukuda S, Harada K, Kunimatsu M, Sakabe T, Yoshida K. 1998. Postischemic reperfusion induces alpha-fodrin proteolysis by m-calpain in the synaptosome and nucleus in rat brain. J Neurochem 70: 2526-2532.
10. Gasche Y, Fujimura M, Morita-Fujimura Y, Copin JC, Kawase M, Massengale J, Chan PH. 1999. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 19: 1020-1028.
11. Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, Lipton SA. 2005. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25: 6401-6408.
12. Harris AK, Ergul A, Kozak A, Machado LS, Johnson MH, Fagan SC. 2005. Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci 3: 6-49.
13. Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, del Zoppo GJ. 1999. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19: 624-633.
14. Jiang X, Namura S, Nagata I. 2001. Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci Lett 305: 41-44.
15. Jin R, Yang G, Li G. 2010. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis 38: 376-385.
16. Lee JK, Park MS, Kim YS, Moon KS, Joo SP, Kim TS, Kim JH, Kim SH. 2007. Photochemically induced cerebral ischemia in a mouse model. Surg Neurol 67: 620-625.
17. Lee SR, Tsuji K, Lee SR, Lo EH. 2004. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 24: 671-678.
18. Lee WH, Sonntag WE, Lee YW. 2010. Aging attenuates radiation-induced expression of pro-inflammatory mediators in rat brain. Neurosci Lett 476: 89-93.
19. Ma H, Fukiage C, Kim YH, Duncan MK, Reed NA, Shih M, Azuma M, Shearer TR. 2001. Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization. J Biol Chem 276: 28525-28531.
20. Manso H, Krug T, Sobral J, Albergaria I, Gaspar G, Ferro JM, Oliveira SA, Vicente AM. 2010. Variants of the matrix metalloproteinase-2 but not the matrix metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet 11: 11-40.
21. Ogier C, Bernard A, Chollet AM, Le Diguardher T, Hanessian S, Charton G, Khrestchatisky M, Rivera S. 2006. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia 54: 272-284.
22. Petcu EB, Sfredel V, Platt D, Herndon JG, Kessler C, Popa-Wagner A. 2008. Cellular and molecular events underlying the dysregulated response of the aged brain to stroke: a mini-review. Gerontology 54: 6-17.
23. Pevsner PH, Eichenbaum JW, Miller DC, Pivawer G, Eichenbaum KD, Stern A, Zakian KL, Koutcher JA. 2001. A photothrombotic model of small early ischemic infarcts in the rat brain with histologic and MRI correlation. J Pharmacol Toxicol Methods 45: 227-230.
24. Piao MS, Lee JK, Park CS, Ryu HS, Kim SH, Kim HS. 2009. Early activation of matrix metalloproteinase-9 is associated with blood-brain barrier disruption after photothrombotic cerebral ischemia in rats. Acta Neurochir 151: 1649-1653.
25. Rami A, Agarwal R, Botez G, Winckler J. 2000. Mu-calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res 866: 299-312.
26. Rivera S, Khrestchatisky M, Kaczmarek L, Rosenberg GA, Jaworski DM. 2010. Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neurosci 30: 15337-15357.
27. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. 1998. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29: 1020-1030.
28. Rosenberg GA, Kornfeld M, Estrada E, Kelley RO, Liotta LA, Stetler-Stevenson WG. 1992. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 576: 203-207.
29. Sbai O, Ould-Yahoui A, Ferhat L, Gueye Y, Bernard A, Charrat E, Mehanna A, Risso JJ, Chauvin JP, Fenouillet E, Rivera S, Khrestchatisky M. 2010. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia 58: 344-366.
30. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R. 2003. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 183: 25-33.
31. Schroeter M, Franke C, Stoll G, Hoehn M. 2001. Dynamic changes of magnetic resonance imaging abnormalities in relation to inflammation and glial responses after photothrombotic cerebral infarction in the rat brain. Acta Neuropathol 101: 114-122.
32. Siegel C, Turtzo C, McCullough LD. 2010. Sex differences in cerebral ischemia: possible molecular mechanisms. J Neurosci Res 88: 2765-2774.
33. Wang JL, Sun Y, Wu S. 2000. Gamma-Irradiation induces matrix metalloproteinase II expression in a p53-dependent manner. Mol Carcinogen 27: 252-258.
34. Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH. 2000. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 20: 7037-7042.
35. Ward WF. 2002. Protein degradation in the aging organism. Prog Mol Subcell Biol 29: 35-42.
36. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD. 1985. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 17: 497-504.
37. Yang Y, Candelario-Jalil E, Thompson JF, Cuadrado E, Estrada EY, Rosell A, Montaner J, Rosenberg GA. 2010. Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia. J Neurochem 112: 134-149.
38. Zhang JW, Gottschall PE. 1997. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification. J Neurosci Methods 76: 15-20.
39. Zhang JW, Deb S, Gottschall PE. 2000. Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid. Neurosci Lett 295: 9-12.
40. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, Wang X, Lo EH. 2006. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12: 441-445.
41. Ziemka-Nalecz M, Zalewska T, Zajac H, Domanska-Janik K. 2003. Decrease of PKC precedes other cellular signs of calpain activation in area CA1 of the hippocampus after transient cerebral ischemia. Neurochem Int 42: 205-214.